Jiangsu Aidea Pharmaceutical Group Co., Ltd. (SHA:688488)
China flag China · Delayed Price · Currency is CNY
11.77
-0.23 (-1.92%)
Nov 6, 2026, 11:30 AM CST

SHA:688488 Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
7.12-19.53-141.2-76.07-124.09-29.99
Depreciation & Amortization
54.8855.1153.1745.137.8530.21
Other Amortization
5.845.623.532.653.512.44
Loss (Gain) From Sale of Assets
-0.08-0.08--0.07-0.03-1.58
Asset Writedown & Restructuring Costs
0.170.1729.3923.80.31-
Loss (Gain) From Sale of Investments
-17.48-17.48-17.73-14.16-14.14-8.09
Provision & Write-off of Bad Debts
0.370.37-3.343.728.87-2.49
Other Operating Activities
83.4659.9354.7211.7736.2110.89
Change in Accounts Receivable
-24.12-24.1276.98-82.92-66.6631.35
Change in Inventory
-21.53-21.53-44.28-52.4-74.62-36.7
Change in Accounts Payable
-26.22-26.22-14.34-8.84118.873.87
Change in Other Net Operating Assets
3.713.71-5.31-2.8--
Operating Cash Flow
67.8117.63-37.5-166.22-92.55-12.37
Operating Cash Flow Growth
------

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-67.57-47.93-44.56-71.2-140.3-94.78
Sale of Property, Plant & Equipment
44.080.121.320.680.01
Cash Acquisitions
-5.04-5.0416.35---
Investment in Securities
22.520.75109135.88-274.75311.12
Other Investing Activities
-53.161.514.197.448.6414.17
Investing Cash Flow
-99.27-26.6385.173.44-405.72230.53

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Long-Term Debt Issued
-477.92410.87395.29205-
Total Debt Issued
639.82477.92410.87395.29205-
Long-Term Debt Repaid
--407.01-340.15-198.33-5.5-2.76
Lease Payments
-2.36-2.36-3.75-3.33-5.5-2.76
Total Debt Repaid
-432.02-407.01-340.15-198.33-5.5-2.76
Net Debt Issued (Repaid)
207.8170.9170.72196.96199.5-2.76
Issuance of Common Stock
---5.48--
Common Dividends Paid
-22.44-20.87-15.85-11.66-3.47-20.16
Other Financing Activities
-130.92-----
Financing Cash Flow
54.4550.0454.86190.78196.03-22.92

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
-0.27-0.1-0.0100.47-0.15
Net Cash Flow
22.7140.94102.4698-301.77195.08

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
0.24-30.3-82.06-237.43-232.85-107.15
Free Cash Flow Growth
------
Free Cash Flow Margin
0.03%-4.21%-19.64%-57.72%-95.34%-41.90%
Free Cash Flow Per Share
0.00-0.07-0.20-0.56-0.56-0.25
Levered Free Cash Flow
-15.71-35.46-9.52-247.6-196.07-81.12
Unlevered Free Cash Flow
-13.4-25.690.08-240.24-193.62-80.97
Free Cash Flow After Leases
-2.12-32.66-85.81-240.76-238.35-109.91

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Income Tax Paid
92.83100.1922.8722.29-6.6711.66
Change in Working Capital
-66.46-66.46-16.04-162.97-41.05-13.77